![Frank Valone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Valone
Keine laufenden Positionen mehr
Profil
Dr. Frank H.
Valone, MD, is Chief Medical Officer at FibroGen, Inc.
Dr. Valone was previously employed as Senior Vice President-Medical Affairs by Bayhill Therapeutics, Inc., EVP-Clinical Development & Regulatory Affairs by Titan Pharmaceuticals, Inc., Clinical Associate Professor by Stanford University, Senior Vice President-Medical & Regulatory Affairs by Dendreon Corp., a Professor by Dartmouth-Hitchcock Medical Center, and an Associate Professor by The University of California, San Francisco.
He received his undergraduate degree from Hamilton College (New York) and a doctorate degree from Harvard University.
Ehemalige bekannte Positionen von Frank Valone
| Unternehmen | Position | Ende |
|---|---|---|
| KYNTRA BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2016 |
Bayhill Therapeutics, Inc.
 Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics | Technik-/Wissenschafts-/F&E-Leiter | - |
| TITAN PHARMACEUTICALS | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 |
| DENDREON CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2001 |
Ausbildung von Frank Valone
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
97
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Titan Pharmaceuticals, Inc.
 Titan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes proprietary therapeutics for the treatment of serious medical disorders | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics | Health Technology |
Hamilton College (New York)
 Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth-Hitchcock Medical Center
 Dartmouth-Hitchcock Medical Center Hospital/Nursing ManagementHealth Services Operates a general medical hospital | Health Services |
